NEW YORK--(BUSINESS WIRE)--CannRx Technology, Inc. (“CannRx” or the “Company,” http://www.cannrx.com/), a privately-held Delaware corporation developing pharmaceutical-grade products from cannabis, announced today that Jeffrey Friedland, noted author, speaker, and opinion leader in the cannabis industry, has joined the Company’s Board of Directors.
